Clinical Case: Application of Rich Fibrin in Growth Factors in the Treatment of Osteonecrosis of the Maxillary by Bisphosphonates
Main Article Content
Abstract
Article Details
References
Kim, J., Kim, S., Kim, M. Leucocyte-rich and platelet-rich fibrin for the treatment ofbisphosphonate-related osteonecrosis of the jaw: aprospective feasibility study. British journal of oral and maxillofacial surgery. 2014; 52(9): p. 854-859.
Fung. P, Bedogni. G, Bedogni. A, Petrie. A, Porter. S, Campisi. G, Bagan. J, Fusco. V, Saia. G, Acham. S, Musto. P, Petrucci.M, Diz. P, Colella. G, Mignogna.M, Pentenero. M, Arduino. P, Lodi G, Maiorana. C, Manfredi. M. Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study. 2016 December.
Maluf. G, Caldas. R, Silva. P. The use of leukocyte-and platelet-rich fibrin (LPRF) in the treatment of medication related osteonecrosis of the jaws (MRONJ). Journal of Oral and Maxillofacial Surgery. 2016 June 6.
Del Fabbro M. et al. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. European Journal of Cancer. 2014; 15(1): p. 62-74.
G. Maluf, M. Correia. Surgery Combined with LPRF in Denosumab Osteonecrosis of the Jaw: Case Report. Brazilian Dental Journal. 2016; 27(3): p. 353-358.
N. Kaibuchi, T. Iwata et al. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model. Acta Biomaterialia. 2016; 15(42): p. 400-410.
Orión. A, Salgado. A, Arriba. L. Nuevas tendencias en regeneración tisular: fibrina rica en plaquetas y leucocitos. Revista Española de Cirugia Oral y Maxilofacial. 2016 Marzo 17; 295.
S. Soydan, S. Uckan. Management of Bisphosphonate-Related Osteonecrosis of the Jaw with a Platelet-Rich Fibrin Membrane: Technical Report. Journal of Oral and Maxillofacial Surgery. 2013; 72(2): p. 1-5.
A. Cieslik et cols. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfusion and Apheresis Science. 2009; 41(1): p. 9-12.
S. Nørholt, J. Hartlev. Surgical treatment of osteonecrosis of the jaw with the use of surgical treatment of osteonecrosis of the jaw with the use of 15 patients. Internacional Journal Oral and Maxillofacial Surgery. 2016; 45(10): p. 1256-1260.
D, Dohan et al. Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Archives of Oral Biology. 2010; 55(3): p. 185-194.
S. Ghanaati et cols. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. Journal of Oral Implantology. 2014; 40(6): p. 679-689.
Shahrokh C. Bagheri, R. Bryan Bell. Current Therapy in Oral and Maxillofacial Surgery St. Louis: Elsevier Inc.; 2012.
Rupel. K, Ottaviani. G, Gobbo. M, Contardo. L, Tirelli. G, Vescovi. P, Di Lenarda. R, Biasotto. M. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncology. 2014 August; 50: p. 1049-1057.
Pathak. H, Mohanty. S, Aadithya. B, Dabas. J. Treatment of oral mucosal lesions by scalpel excision and PRF membrane grafting: a review of 26 sites. Journal of Oral and Maxillofacial Surgery. 2016 March; 13.